Cardiovascular Disease Diagnostics - A World Market Intelligence Report

1.METHODOLOGY
Study Reliability and Reporting Limitations
Disclaimers
Quantitative Techniques & Reporting Level
2.GLOBAL MARKET OVERVIEW AND OUTLOOK
Cardiology Diagnostic Imaging: Future Outlook
Heart - Facts and Figures
Swift Growth in Cardiovascular Disease Devices Market
Cardiovascular Diseases Damaging Human Health
Mounting Healthcare Costs- "A Real Concern for Economies"
Competition in the Cardiac Diagnostics Market
Market Trends
Advancement of POC Testing Propels Cardiovascular Diagnostics Market
Demand on Rise for POC Cardiac Markers
Minimal Invasive Procedure Hogs the Limelight of Cardiovascular Treatment
Advancements in Alternate-Site Coagulation Monitoring
Novel Imaging Techniques Boost In vivo Diagnostic Market
Strong Demand for Risk Assessment Markers
New Technologies Bring Diagnostics Closer to Patients
Trends Cited in the Imaging Technologies Market
CT Scanners
MRI
Move Towards Efficient Patient Data Management
3.PRODUCT FACTS
4.CORPORATE DEVELOPMENTS
Siemens Medical acquires Dade Behring
Inverness Medical Innovations Acquires Cholestech
Acrongenomics, Pearson and Molecular Enter into Joint Venture
Cholestech Teams Up with Onsite Health Diagnostics
Lipomics to Collaborate with Agilent Technologies to Develop Diagnostic Tests.
Transgenomic and Fiuotecnica Renew Collaboration Agreement
Alteon and BioRap Technologies Enter into an Agreement
IM Medical Acquires New Technology for Detecting Cardiovascular Diseases
Medtronic Establishes New Business Entity
Siemens Medical Acquires Bayer Healthcare’s Diagnostics Unit
Philips Rolls Out 256-slice CT scanner, Brilliance iCT Scanner
Royal Philips Launches Live 3D Transesophageal Echocardiogram Probe
GE Healthcare Launches Vivid e Ultrasound Systems
Cardionetics Launches ECG Monitor for 24-Hour Real-Time Cardiac Diagnosis
Siemens Launches Imaging Release for the ACUSON Sequoia Platform
GE Healthcare Launches Version 2.0 of Centricity Cardiology CA1000
GE Healthcare Introduces New Capabilities to CardioSoft Diagnostic Software
GE Healthcare’s Lightspeed VCT Offers Imaging at 70% Lower Exposure
Roche Diagnostics Launches cobas h 232 Portable Cardiac Marker System (Outside US)
Royal Philips Launches New Imaging Tool for Complex Cardiac Arrhythmias
5.MAJOR PLAYERS
Abbott Diagnostics (USA)
Biosite, Inc. (USA)
Cambridge Heart, Inc. (USA)
Cholestech Corp. (USA)
EP Medsystems (USA)
GE HealthCare (UK)
Liposcience, Inc. (USA)
Philips Healthcare (USA)
Roche Diagnostics (Switzerland)
Siemens Healthcare (Germany)
6.GLOBAL MARKET ANALYTICS
7.THE UNITED STATES
Cardio Vascular Disease (CVD) - An Overview
Startling facts related to Stroke in US
Incidence of Coronary Heart Disease
Mortality rate of CHD
Arrhythmias
CAD Diagnostics
PVD Diagnostics
Medicare Reimbursement Set for CPT Code 83704
Competitive Glance
Point-of-Care (POC) Diagnostic Market in the US
8.CANADA
9.JAPAN
10.EUROPE
a.France
b.Germany
c.Italy
d.The United Kingdom
e.Spain
f.Russia
g.Rest of Europe
11.ASIA-PACIFIC
Cardiovascular Market in Asia-Pacific
China
Cardiovascular Disease Patients Overview
Chinese Cardiovascular Disease Treatment as a Part of Overall Health Care Industry
12. THE MIDDLE EAST
13.LATIN AMERICA
Exhibits
Table 1: Global Cardiovascular Disease Diagnostics Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 2: Percentage Breakdown of Global Cardiovascular Disease Diagnostics Market by Region for the Years 2008 & 2009 2009
Table 3: Global Cardiovascular In Vitro Diagnostics Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 4: Percentage Breakdown of Global Cardiovascular In Vitro Diagnostics Market by Region for the Years 2008 & 2009 2009
Table 5: Global Cardiovascular In Vivo Diagnostics Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 6: Percentage Breakdown of Global Cardiovascular In Vivo Diagnostics Market by Region for the Years 2008 & 2009 2009
Table 7: Percentage Breakdown of Leading POC Cardiac Manufacturer Value Sales in the US -
Table 8: Cardiovascular Disease Diagnostics Market by Product Segment in the US: 2007-2015 (Sales in US$ Million)
Table 9: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in the US for the Years 2008 & 2009 2009
Table 10: Cardiovascular Disease Diagnostics Market by Product Segment in Canada: 2007-2015 (Sales in US$ Million)
Table 11: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in Canada for the Years 2008 & 2009 2009
Table 12: Cardiovascular Disease Diagnostics Market by Product Segment in Japan: 2007-2015 (Sales in US$ Million)
Table 13: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in Japan for the Years 2008 & 2009 2009
Table 14: Cardiovascular Disease Diagnostics Market by Region in Europe: 2007-2015 (Sales in US$ Million)
Table 15: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Region in Europe for the Years 2008 & 2009 2009
Table 16: Cardiovascular Disease Diagnostics Market by Product Segment in Europe: 2007-2015 (Sales in US$ Million)
Table 17: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in Europe for the Years 2008 & 2009 2009
Table 18: Cardiovascular Disease Diagnostics Market by Product Segment in France: 2007-2015 (Sales in US$ Million)
Table 19: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in France for the Years 2008 & 2009 2009
Table 20: Cardiovascular Disease Diagnostics Market by Product Segment in Germany: 2007-2015 (Sales in US$ Million)
Table 21: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in Germany for the Years 2008 & 2009 2009
Table 22: Cardiovascular Disease Diagnostics Market by Product Segment in Italy: 2007-2015 (Sales in US$ Million)
Table 23: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in Italy for the Years 2008 & 2009 2009
Table 24: Cardiovascular Disease Diagnostics Market by Product Segment in the UK: 2007-2015 (Sales in US$ Million)
Table 25: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in the UK for the Years 2008 & 2009 2009
Table 26: Cardiovascular Disease Diagnostics Market by Product Segment in Spain: 2007-2015 (Sales in US$ Million)
Table 27: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in Spain for the Years 2008 & 2009 2009
Table 28: Cardiovascular Disease Diagnostics Market by Product Segment in Russia: 2007-2015 (Sales in US$ Million)
Table 29: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in Russia for the Years 2008 & 2009 2009
Table 30: Cardiovascular Disease Diagnostics Market by Product Segment in Rest of Europe: 2007-2015 (Sales in US$ Million)
Table 31: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in Rest of Europe for the Years 2008 & 2009 2009
Table 32: Cardiovascular Disease Diagnostics Market by Product Segment in Asia-Pacific: 2007-2015 (Sales in US$ Million)
Table 33: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in Asia-Pacific for the Years 2008 & 2009 2009
Table 34: Cardiovascular Disease Diagnostics Market by Product Segment in Middle East: 2007-2015 (Sales in US$ Million)
Table 35: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in Middle East for the Years 2008 & 2009 2009
Table 36: Cardiovascular Disease Diagnostics Market by Product Segment in Latin America: 2007-2015 (Sales in US$ Million)
Table 37: Percentage Breakdown of Cardiovascular Disease Diagnostics Market by Product Segment in Latin America for the Years 2008 & 2009 2009
Companies Profiled